Notable Movers – Nuvilex Inc (OTCMKTS:NVLX), mCig Inc (OTCBB:MCIG … – Techsonian (press release)

Birmingham, West Midlands — (TechSonian) — 15 May 2014 —Nuvilex Inc (OTCMKTS:NVLX) declared last week that it signed a contract with the University of Northern Colorado to perform initial studies in the development of cancer treatments that merge the proprietary live-cell encapsulation technology Cell-in-a-Box® with constituents of cannabis known as cannabinoids.

Nuvilex Inc (OTCMKTS:NVLX) was trading lower by -0.47% to $0.316. So far, around 272,232 shares have changed hands in this session. After opening at $0.32, the stock hit as high as $0.32. However, it traded between $0.02 and $0.62 over the last twelve months.

Has NVLX Found The Bottom and Ready To Move Up? Find Out Here

mCig Inc (OTCBB:MCIG) declared that it has initiated the implementation of best-in class testing, quality control, and chain of custody standards within the VitaCig manufacturing process.

mCig Inc (OTCBB:MCIG) was at $0.404, showing a -3.81% decrease. Around 297,790 shares have been traded, versus an-average trading volume of 3.44 million shares. The company is now valued at around $109.13 million.

Has MCIG Found The Bottom And Ready To Gain Momentum? Find Out Here

Genco Shipping & Trading Limited (OTCMKTS:GNKOQ) is engaged in the ocean transportation of drybulk cargoes through the ownership and operation of drybulk carrier vessels worldwide. It transports iron ore, coal, grain, steel products, and other drybulk cargoes. The company charters its vessels primarily to trading houses, which include commodities traders; producers; and government-owned entities.

Genco Shipping & Trading Limited (OTCMKTS:GNKOQ) moved -3.35 per cent lower at $2.02 and is trading between $1.90and $2.09 after opening the day at $2.08. Its performance over the last five days remained 18.82%, which stands at 14.12% for a month. Going back further than one month, 1-year performance after recent close was 49.63%.

Why Should Investors Buy GNKOQ After the Recent Fall? Just Go Here and Find Out

Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) recently declared that new data on nine accepted and 18 investigational medicines will be presented during the 50th American Society of Clinical Oncology (ASCO) Annual Meeting. Of the more than 320 abstracts on Genentech medicines, more than 40 have been accepted for oral presentation.

Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) shares rise today, gaining per cent to $37.37. Around 263,057 shares changed hands so far in this session compared to an-average trading volume of 838,680 shares.

Why Should Investors Buy RHHBY After The Recent Gain? Just Go Here and Find Out

This entry passed through the Full-Text RSS service — if this is your content and you’re reading it on someone else’s site, please read the FAQ at